PETER MCKENNA: Open Payments
NPI 1417244773 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 106 payments from 19 companies in 2025. Trend: 2023 $4,808 · 2024 $5,978 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $323 |
| Janssen Biotech, Inc. | 12 | $272 |
| GENZYME CORPORATION | 9 | $265 |
| PFIZER INC. | 9 | $173 |
| Novartis Pharmaceuticals Corporation | 28 | $145 |
| Lilly USA, LLC | 5 | $83 |
| UCB, Inc. | 4 | $80 |
| Organon LLC | 3 | $42 |
| Amgen Inc. | 2 | $40 |
| Chiesi USA, Inc. | 1 | $30 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, RINVOQ, COSENTYX, Bimzelx, AYVAKIT.
Industry payments across NY — which companies pay providers there.
